A5041743860- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Renal and Vascular Pathologies
- Radiomics and Machine Learning in Medical Imaging
- Economic and Financial Impacts of Cancer
- Global Cancer Incidence and Screening
- Multiple and Secondary Primary Cancers
- Renal and related cancers
- MRI in cancer diagnosis
- Chronic Kidney Disease and Diabetes
- Pediatric Urology and Nephrology Studies
- Cancer, Lipids, and Metabolism
- Advanced X-ray and CT Imaging
- Bladder and Urothelial Cancer Treatments
- Aortic aneurysm repair treatments
- Cardiac, Anesthesia and Surgical Outcomes
- Cancer Genomics and Diagnostics
- Viral Infections and Vectors
- Neurological and metabolic disorders
- Bariatric Surgery and Outcomes
- Cardiovascular Health and Risk Factors
- Organ Donation and Transplantation
- Esophageal Cancer Research and Treatment
- Insurance, Mortality, Demography, Risk Management
Cleveland Clinic
2022-2025
Ohio Gastroenterology and Liver Institute
2023-2025
University of Connecticut
2024-2025
Case Western Reserve University
2024
University School
2024
University of Hartford
2024
Ain Shams University
2023
Kidney Associates
2023
Saint Joseph University
2022
Collaborative Research Group
2022
In recent decades, variability in the incidence and mortality of kidney cancer (KC) has been reported. This study aimed to compare trends incidence, mortality, disability-adjusted life years (DALY) KC between European Union (EU) 15 + countries 6 World Health Organization (WHO) regions. The data Age-standardized rates (ASIRs), age-standardized (ASMRs), DALYs were extracted from Global Burden Disease database. Joinpoint regression was employed examine trends. From 1990 2019, ASIR increased...
Existing data on the impact of Hispanic ethnicity outcomes for patients with renal cell carcinoma (RCC) is mixed. The authors investigated and non-Hispanic White (NHW) advanced RCC receiving systemic therapy at large academic cancer centers using International Metastatic Renal Cell Carcinoma Database (IMDC).
We consider the problem of renal mass risk classification to support doctors in adjuvant treatment decisions following nephrectomy. Recommendation therapy based on appearance poses two major challenges: first, morphologic patterns may sometimes overlap across subtypes varying risks. Second, interobserver variability is large. These complexities encourage use computational models as accurate noninvasive tools find relevant relationships between individual perioperative characteristics and...
Abstract Accurate prediction of new baseline GFR (NBGFR) after radical nephrectomy (RN) can inform clinical management and patient counseling whenever RN is a strong consideration. Preoperative global GFR, split renal function (SRF), functional compensation (RFC) are fundamentally important for the accurate NBGFR post-RN. While SRF has traditionally been obtained from nuclear scans (NRS), differential parenchymal volume analysis (PVA) via software may be more accurate. A simplified approach...
Lung cancer is the leading cause of cancer-related deaths in United States. This study aims to analyze lung incidence, mortality, and related statistics from 1990 2019, focusing on national- state-level trends exploring potential disparities between sexes.The Global Burden Disease database was used extract tracheal, bronchus, mortality data 2019 for both males females across all states Age-standardized incidence rates, age-standardized disability-adjusted life years (DALYs),...
Objective To automate the generation of three validated nephrometry scoring systems on preoperative computerised tomography (CT) scans by developing artificial intelligence (AI)‐based image processing methods. Subsequently, we aimed to evaluate ability these scores predict meaningful pathological and perioperative outcomes. Patients Methods A total 300 patients with CT early arterial contrast phase were identified from a cohort 544 consecutive undergoing surgical extirpation for suspected...
You have accessJournal of UrologyProstate Cancer: Localized: Active Surveillance II (PD26)1 May 2024PD26-02 THE PROLONGED LOW RISK OF CLINICALLY SIGNIFICANT PROSTATE CANCER DIAGNOSIS IN MEN WITH AN ELEVATED PSA BUT IsoPSA Nour Abdallah, Rebecca Campbell, Tarik Benidir, Andrew Wood, Zaeem Lone, Ao Zhang, Onuralp Ergun, Caleb Curry, Patrick Michael, Jay Chavali, Samuel Haywood, Zeyad Schwen, Ruben Olivares, Jihad Kaouk, Robert Abouassaly, Eric Klein, and Christopher Weight AbdallahNour...
PURPOSE The acid phosphatase 1 ( ACP1 ) gene encodes low-molecular-weight protein tyrosine phosphatase, which is overexpressed in prostate cancer (PC) and a potential therapeutic target. We analyzed expression primary/metastatic PC its association with molecular profiles clinical outcomes. METHODS NextGen sequencing of DNA (592-gene/whole-exome sequencing)/RNA(whole-transcriptome sequencing) was performed for 5,028 specimens. -High/ -Low defined as quartile (Q4/1) RNA transcripts per million...
Purpose: Black patients with renal tumors are less likely to undergo partial nephrectomy (PN) despite a higher risk of chronic kidney disease (CKD). Racialized equations estimating glomerular filtration rate (eGFR) estimate 15% 20% function for as opposed non-Black patients. Whether raced-modified eGFR affect the use nephron-sparing surgery in has not yet been explored. Materials and Methods: This is single-center, retrospective review 6327 consecutive who underwent PN (n = 3533) or radical...
4563 Background: Kidney cancer (KC) is one of the leading causes mortality, with recent data showing an increase in incidence and mortality worldwide. Gender, racial, ethnic disparities can impact KC outcomes. Studies investigating outcomes diverse patient populations spanning cytokine, targeted therapy immunotherapy eras have been limited. This study aims to investigate trends age-adjusted rates (ASMR) by gender, race, ethnicity US at national state levels. Methods: We utilized Center for...
624 Background: The Preoperative Aspects and Dimensions Used for Anatomical Classification (PADUA) score is a validated predictor of patient’s perioperative outcomes following partial nephrectomy. use fully automated, unbiased time sensitive PADUA scoring system novel concept that may help circumvent PADUA’s widespread adoptability. We sought to automate the preoperative computed tomography scans (CT) using machine-learning-generated (P-AI). In doing so, we aimed compare P-AI’s ability...